TIGERQ

A New Gold Standard Accuracy in Sequencing Analysis - TIGERQ provides Accurate & Accessible Gene Editing analysis solutions to accelerate biomedical research.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Lund, Sweden
  • Currency SEK
  • Founded January 2018
  • Employees 3
  • Incorporation Type LLC
  • Website tigerq.com

Company Summary

TIGERQ is looking to transform Next Generation Sequencing accuracy.

Today, we solve a foundational problem in the field of Gene Editing (CRISPR) academic research - lack of accurate Gene Editing efficiency analysis - a problem best solved with accurate sequencing technology.

Tomorrow, we aim to apply our new gold standard accuracy towards the patients that need it most. TIGERQ is the clinical grade analysis of the future.

Team

  • Co-Founder and CEO

    5th year PhD student Lund University - CRISPR Gene Editing, Next Generation Sequencing expertise.

    2 years, Research Assistant at Brigham and Women's Hospital and the Broad Institute (Harvard Medical School affiliate) - CRISPR Gene Editing expertise.

    4 years, Duke University, Gene Editing research, Biomedical Engineering degree.

    4 years IDF officer - leadership expertise.

  • Jonas Larsson
    Co-Founder and Board Member

    Professor at Lund University for Molecular Medicine and Gene Therapy.

    Over 20 years experience in competitive research in high throughput screens, sequencing, and stem cell engineering.

    Postdoctoral fellowship at Harvard Medical School.
    Access to global academic network in respective fields.
    Expertise in management, leadership, and scientific excellence.

  • Terese Jönsson Yudovich
    Production Manager

    Licensed pharmacist with sales experience and experienced biomedical researcher. Critical technical skills, regulatory perspective, and competitive research network.

    2 years PhD research studies at Harvard Medical School and 1.5 years research experience at Lund University.
    MS is pharmaceutical science Gothenburg University with MS thesis at Harvard Medical School.

Advisors

  • Tim Kovac
    Unconfirmed
    Thomas Unt
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free